This is a discussion on Obama to back biogenerics within the Biotechnology News forum, part of the Industry News and Updates category; In one of the most closely-watched biotech policy initiatives underway in Washington, President Obama appears ready to call for ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
In one of the most closely-watched biotech policy initiatives underway in Washington, President Obama appears ready to call for a regulatory pathway to approve generic biotech therapies, also known as biosimilars. That move would have a major impact on a biotech company like Amgen, which has anemia drugs that will quickly face new generic competition. And it will be a boon to biopharma companies like Merck, which are jumping into this space in a big way. Report
More... |
![]() |
| Thread Tools | |
| Display Modes | |
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| More biotechs lobby against biogenerics | industry_news | Biotechnology News | 0 | 12-10-2008 03:24 AM |
| Amgen, Amylin lobby against biogenerics | industry_news | Biotechnology News | 0 | 12-05-2008 12:25 PM |
| Guidelines Issued for Management of Low Back Pain | industry_news | Other Clinical Pharmacy News | 0 | 10-23-2008 02:45 PM |
| Small biotech campaigns for biogenerics law | industry_news | Biotechnology News | 0 | 08-14-2008 12:53 PM |
| Committee votes to back GSK/Ligand's Promacta | industry_news | Biotechnology News | 0 | 06-02-2008 04:33 PM |